Natural history study for homocystinuria due to CBS deficiency
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This study mainly observes what happens in people with homocystinuria caused by a CBS gene deficiency over time. It helps doctors better understand the condition’s natural course and may guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a clinical diagnosis of homocystinuria (an imbalance of certain blood chemicals).
- Your age is between 1 and 65 years.
- You (or your child, if applicable) can give consent/assent to join the study.
- You’re able and willing to follow study visits and procedures.
- In the past 6 months, you did not take an experimental treatment for homocystinuria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with urea cycle disorders (and some people who are very likely to have one) over time. It aims to better understand how these rare enzyme problems affect health, using medical tests and family information.
This study surveys how classical homocystinuria (CBS deficiency) affects daily life and well-being. It includes patients age 8 and up, parents of younger or cognitively impaired children, and medical experts.
This study looks at eye problems in people with homocystinuria. It will review medical records from 2018 to 2022 to find out how common eye issues are and what might increase the risk.
This study tests a new enzyme replacement therapy called pegtibatinase for children with classical homocystinuria (HCU). The enzyme helps break down homocysteine, which may lower its levels in the blood and reduce symptoms.
This trial tests whether adding a special diet and cysteine supplements can help children with a specific type of homocystinuria grow better and control their lab results. It is for Qatari children who are already following a diet for this condition.
This study looks at how cysteamine affects the bone health of people with nephropathic cystinosis, a rare genetic condition. It includes children and adults who are already taking cysteamine by mouth and will follow the study plan closely.
Hear when a new Homocystinuria Due to CBS Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.